NCT02915393

Brief Summary

Spleen Deficiency Syndrome(SDS)is a widely researched issue, but due to the limitations of the research methods, the scientific mechanism of SDS is biased and not comprehensive. SDS would be researched in this project deeply and systematically with modern life-scientific methods. Based on the previous work, the participants, with SDS, suffering from Qi deficiency syndrome--chronic superficial gastritis--chronic atrophic gastritis--gastric cancer would be included, and the corresponding research would be conducted at the molecular-cell-gastric tissue level, and at the same time, systematical biological database of SDS would be built by systematical biological methods, such as pioneered SPARS sequencing technology created in our research group, proteomics and metabonomics. Under the above work, the investigators would conduct data mining and molecular network analysis, and then verify the key functions. By analyzing the systematical biological features of syndrome and its relationships with constitution and disease, this study would provide a new basis for objective reality of syndrome, and also offer a crucial premise of revealing biological basis for syndrome correctly, which is of important theoretical and practical significance.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2016

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

September 17, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 27, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

September 27, 2016

Status Verified

September 1, 2016

Enrollment Period

1 year

First QC Date

September 17, 2016

Last Update Submit

September 23, 2016

Conditions

Keywords

Chronic GastritisQi Deficiency ConstitutionNext Generation SequencingProteomicsMetabonomics

Outcome Measures

Primary Outcomes (3)

  • Examination of the stomach with an endoscope.

    Endoscopic diagnosis standard of chronic gastritis according to Chinese Society of Digestive Endoscopy.

    at the beginning of the enrollment

  • Pathological biopsy of gastric mucosa.

    Pathological diagnosis standard of chronic gastritis according to Chinese Society of Gastroenterology.Pathological diagnosis standard of gastric cancer according to Ministry of Health P.R.China

    at the beginning of the enrollment

  • Detection of helicobacter pylori by Urea Breath Test(UBT)

    at the beginning of the enrollment

Secondary Outcomes (3)

  • Analysis of gastric mucosa/venous blood/urine by system biology techniques

    Three measurements within 1 year

  • Constitutional classification of TCM assessed by the Traditional Chinese Medicine Physical Constitution Scale

    at the beginning of the enrollment

  • TCM syndrome type diagnosed by two professional TCM doctors

    at the beginning of the enrollment

Study Arms (9)

Healthy Volunteers (BC)

Healthy Volunteers with Balanced Constitution(n=10).

Healthy Volunteers(QC)

Healthy Volunteers with Qi Deficiency Constitution(n=10).

Healthy Volunteers(DC)

Healthy Volunteers with Damp-heat Constitution(n=10).

Superficial Gastritis(SDS)

Superficial Gastritis with Spleen-qi Deficiency Syndrome(n=10).

Superficial Gastritis(DS)

Superficial Gastritis with Damp-heat Syndrome(n=10).

Atrophic Gastritis(SDS)

Atrophic Gastritis with Spleen-qi Deficiency Syndrome(n=10).

Atrophic Gastritis(DS)

Atrophic Gastritis with Damp-heat Syndrome(n=10).

Gastric Cancer(SDS)

Gastric Cancer with Spleen-qi Deficiency Syndrome(n=10).

Gastric Cancer(DS)

Gastric Cancer with Damp-heat Syndrome(n=10).

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A total of 90 cases will be gathered between August, 2016 and September, 2017. All the cases include: ①10 healthy volunteers in Beijing with balanced constitution, 10 with Qi Deficient Constitution (Spleen-qi Deficiency Syndrome) and 10 with Damp-heat Constitution. ②Patients in Dongfang Hospital diagnosed as chronic superficial gastritis,chronic atrophic gastritis or gastric cancer, 20 for each disease and half of each with Spleen-qi Deficiency Syndrome, half with Spleen Damp-heat Syndrome.

You may qualify if:

  • Aged between 18 and 65 years.
  • No apparent abnormality in the routine blood test, urinalysis, routine stool \& fecal occult blood test, biochemical test, chest radiograph and electrocardiogram(ECG).
  • The endoscopic diagnoses of chronic superficial gastritis, chronic atrophic gastritis and gastric cancer conform to the corresponding pathological diagnoses
  • TCM diagnoses of Spleen-qi Deficiency Syndrome or Spleen Damp-heat Syndrome.
  • Voluntary participation.
  • Having given written informed consent.

You may not qualify if:

  • Gastropathy with special causes, such as acute gastritis, gastrinoma, chronic gastritis resulting from special causes (like granulomatous gastritis, lymphocytic gastritis, eosinophilic gastritis, gastritis after gastric operation) peptic ulcer, other malignant tumors of stomach (like gastric lymphoma, gastri stromal tumor, carcinoid tumor, malignant hemangioma, squamous-cell carcinoma, primary gastric choriocarcinoma and metastatic gastric tumor), benign gastritic tumors that originate from epithelium or submucosa (epithelial tumors like adenomatous polyps and hyperplastic polyps, stromal tumors like benign stromal tumor, neuronal tumor and pseudolymphoma).
  • Combined with other digestive diseases (like gastroesophageal reflux, esophageal varices, acute and chronic hepatitis and cirrhosis arising from various causes, acute/chronic pancreatitis and acute/chronic cholecystitis).
  • Combined with other severe systemic diseases such as respiratory failure, severe cardiovascular and cerebrovascular, immune system, urinary and mental disorders diseases.
  • Pregnancy, or planning pregnancy during the trial or within three month period thereafter.
  • Participation in any clinical trial including blood sampling and/or administration of substances up to 90 days before Day 01 of this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • You L, Zhang S, Li T, Sang X, Li K, Wang W, Gao X, Wu J, Huang G, Wang T, Xu A. Integrated analyses of miRNA and mRNA profiles in leukocytes and serums in traditional Chinese medicine (TCM)-defined Pi-qi-deficiency syndrome and Pi-wei damp-heat syndrome resulting from chronic atrophic gastritis. Chin Med. 2021 Jan 6;16(1):4. doi: 10.1186/s13020-020-00416-9.

Biospecimen

Retention: SAMPLES WITH DNA

frozen tissue, whole blood

MeSH Terms

Conditions

Gastritis, AtrophicStomach Neoplasms

Condition Hierarchy (Ancestors)

GastritisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesStomach DiseasesGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasms

Study Officials

  • Anlong Xu

    Beijing University of Chinese Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Leiming You

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
President

Study Record Dates

First Submitted

September 17, 2016

First Posted

September 27, 2016

Study Start

September 1, 2016

Primary Completion

September 1, 2017

Study Completion

December 1, 2019

Last Updated

September 27, 2016

Record last verified: 2016-09